ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

SLRX Salarius Pharmaceuticals Inc

0.501
0.00 (0.00%)
2024年5月6日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Salarius Pharmaceuticals Inc SLRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.501 09:00:00
始値 安値 高値 終値 前日終値
0.501
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2305:05GLOBESalarius Pharmaceuticals Reports Fourth Quarter and Full..
2024/3/0706:02EDGAR2Form 8-K - Current report
2024/2/2306:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2306:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2306:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2222:00GLOBESalarius Provides Update on Strategic Review Process and..
2024/1/1622:00GLOBESalarius Pharmaceuticals Issued U.S. Patent for..
2024/1/0322:30GLOBEInvestigator-initiated Phase 1/2 Clinical Trial Using..
2023/11/1007:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0722:30GLOBESalarius Completes FDA Type B Meeting for Seclidemstat Ewing..
2023/10/2804:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/9/0706:09EDGAR2Form 8-K - Current report
2023/8/1105:14EDGAR2Form 8-K - Current report
2023/8/1105:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:05GLOBESalarius Pharmaceuticals Reports Second Quarter 2023..
2023/8/0905:05GLOBESalarius Pharmaceuticals Announces Plans to Explore..
2023/7/1222:22EDGAR2Form 8-K - Current report
2023/7/1121:30GLOBESalarius Pharmaceuticals Receives FDA Clearance of SP-3164..
2023/6/1221:00GLOBESalarius Pharmaceuticals Presents SP-3164 Targeted Protein..
2023/5/1705:05GLOBESalarius Pharmaceuticals Announces Closing of $6 Million..
2023/5/1221:00GLOBESalarius Pharmaceuticals Announces $6 Million Private..
2023/5/1121:00GLOBESalarius Pharmaceuticals Reports First Quarter 2023..
2023/5/0921:00GLOBEFDA Removes Partial Clinical Hold on Salarius..

最近閲覧した銘柄

Delayed Upgrade Clock